Heartflow, Inc. Common Stock
NASDAQ:HTFLMedical - Healthcare Information Services
+$0.39 today
- Market cap
- $4.03B
- Beta
- 1.91
- P/E (TTM)
- -109.5
- EPS (TTM)
- -$0.30
Volume 1.33M
Average 1.33M
HTFL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Heartflow, Inc. Common StockNASDAQ: HTFL
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development growth accelerates
Q3 FY2026 research & development of $29.49M rose 70.5% year over year, ahead of the +64.1% change in trailing-twelve-month research & development. Sequentially, it rose 12.3% from the prior quarter.
Context
- Research & development amounted to 36.9% of revenue in FY2025, up 2.3 pp from a year earlier.
- Research & development increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether quarterly growth of +70.5% holds above the trailing-twelve-month pace of +64.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 64.92M USD
- Year-over-year change
- +49.2%
- 2-year CAGR
- +34.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 64.92M | +49.2% |
| FY2024 | 2024-12-31 | 43.52M | +21.4% |
| FY2023 | 2023-12-31 | 35.85M | — |
Research & Development vs competitors
How HTFL compares with its peers on the latest reported figures
No competitor Research & Development figures are available to compare.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 87.17M | 125.81M | 176.03M |
| Cost of Revenue | 29.12M | 31.36M | 40.84M |
| Gross Profit | 58.05M | 94.45M | 135.2M |
| Gross Margin | 66.6% | 75.1% | 76.8% |
| Research & Development | 35.85M | 43.52M | 64.92M |
| Selling, General & Admin | 95.11M | 112.15M | 134.35M |
| Operating Expenses | 130.97M | 155.67M | 199.26M |
| Depreciation & Amortization | 7.59M | 8.14M | 8.57M |
| EBITDA | (62.83M) | (65.47M) | (93.12M) |
| EBITDA Margin | -72.1% | -52.0% | -52.9% |
| Operating Income | (72.91M) | (61.22M) | (64.07M) |
| Operating Margin | -83.6% | -48.7% | -36.4% |
| Interest Income | 5.46M | 4.07M | 5.54M |
| Interest Expense | 24.69M | 22.77M | 15.17M |
| Other Income / Expenses | (22.19M) | (35.15M) | (52.8M) |
| Income Before Tax | (95.11M) | (96.37M) | (116.87M) |
| Pre-Tax Margin | -109.1% | -76.6% | -66.4% |
| Income Tax Expense | 547K | 53K | (76K) |
| Net Income | (95.66M) | (96.43M) | (116.79M) |
| Net Margin | -109.7% | -76.6% | -66.3% |
| EPS (Basic) | (1.94) | (1.53) | (1.37) |
| EPS (Diluted) | (1.94) | (1.53) | (1.37) |
| Weighted Avg Shares | 63.86M | 63.06M | 85.28M |
| Weighted Avg Shares (Diluted) | 63.86M | 63.06M | 85.28M |
Heartflow, Inc. Common Stock
NASDAQ:HTFL
Intrinsic Alpha fair value
Locked
Current Price
$45.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.